{"id":"https://openalex.org/W4282963387","doi":"https://doi.org/10.1158/1538-7445.am2022-ct004","title":"Abstract CT004: Product attributes of axicabtagene ciloleucel (axi-cel) that associate differentially with efficacy and toxicity in second-line large B-cell lymphoma","display_name":"Abstract CT004: Product attributes of axicabtagene ciloleucel (axi-cel) that associate differentially with efficacy and toxicity in second-line large B-cell lymphoma","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282963387","doi":"https://doi.org/10.1158/1538-7445.am2022-ct004"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-ct004","doi":"https://doi.org/10.1158/1538-7445.am2022-ct004","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct004","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037111172","display_name":"Simone Filosto","orcid":"https://orcid.org/0000-0002-7854-998X","observed_orcids":["https://orcid.org/0000-0002-7854-998X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simone Filosto","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064789111","display_name":"Saran Vardhanabhuti","orcid":"https://orcid.org/0000-0003-1558-2755","observed_orcids":["https://orcid.org/0000-0003-1558-2755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saran Vardhanabhuti","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047288670","display_name":"Miguel \u00c1ngel Canales","orcid":"https://orcid.org/0000-0002-6550-2621","observed_orcids":["https://orcid.org/0000-0002-6550-2621"]},"institutions":[{"id":"https://openalex.org/I2800562746","display_name":"Hospital Universitario La Paz","ror":"https://ror.org/01s1q0w69","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800562746"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Canales","raw_affiliation_strings":["2Hospital Universitario La Paz, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hospital Universitario La Paz, Madrid, Spain;","institution_ids":["https://openalex.org/I2800562746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041008830","display_name":"Xavier Poir\u00e9","orcid":"https://orcid.org/0000-0003-1897-0227","observed_orcids":["https://orcid.org/0000-0003-1897-0227"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Xavier Poir\u00e9","raw_affiliation_strings":["3Cliniques Universitaires Saint-Luc, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cliniques Universitaires Saint-Luc, Brussels, Belgium;","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077959781","display_name":"Lazaros J. Lekakis","orcid":"https://orcid.org/0009-0008-2077-7032","observed_orcids":["https://orcid.org/0009-0008-2077-7032"]},"institutions":[{"id":"https://openalex.org/I4210101935","display_name":"University of Miami Health System","ror":"https://ror.org/00zw9nc64","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lazaros J. Lekakis","raw_affiliation_strings":["4University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL;","institution_ids":["https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081213752","display_name":"Sven de Vos","orcid":"https://orcid.org/0000-0002-6715-4851","observed_orcids":["https://orcid.org/0000-0002-6715-4851"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sven de Vos","raw_affiliation_strings":["5Division of Hematology and Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Hematology and Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023426390","display_name":"Craig Anthony Portell","orcid":"https://orcid.org/0000-0002-9487-8345","observed_orcids":["https://orcid.org/0000-0002-9487-8345"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig A. Portell","raw_affiliation_strings":["6Division of Hematology and Oncology, University of Virginia, Charlottesville, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Hematology and Oncology, University of Virginia, Charlottesville, VA;","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102002763","display_name":"Zixing Wang","orcid":"https://orcid.org/0000-0002-9617-2493","observed_orcids":["https://orcid.org/0000-0002-9617-2493","https://orcid.org/0009-0007-2356-8466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zixing Wang","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080227134","display_name":"Christina Ann To","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina To","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Cheng","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102739659","display_name":"Justin Chou","orcid":"https://orcid.org/0000-0002-7310-3225","observed_orcids":["https://orcid.org/0000-0002-7310-3225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin Chou","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064185471","display_name":"Adrian I Bot","orcid":"https://orcid.org/0009-0006-3137-2271","observed_orcids":["https://orcid.org/0009-0006-3137-2271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian Bot","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079791833","display_name":"Rhine R. Shen","orcid":"https://orcid.org/0009-0000-8883-0727","observed_orcids":["https://orcid.org/0009-0000-8883-0727"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rhine Shen","raw_affiliation_strings":["1Kite, a Gilead Company, Santa Monica, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Kite, a Gilead Company, Santa Monica, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021496101","display_name":"Jason R. Westin","orcid":"https://orcid.org/0000-0002-1824-2337","observed_orcids":["https://orcid.org/0000-0002-1824-2337"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason R. Westin","raw_affiliation_strings":["7The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"CT004","last_page":"CT004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/large-b-cell-lymphoma","display_name":"large B-cell lymphoma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ccr7","display_name":"CCR7","score":0.5839999914169312},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6779999732971191},{"id":"https://openalex.org/keywords/neurological-events","display_name":"neurological events","score":0.8299999833106995},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cytokine-storm","display_name":"cytokine storm","score":0.5059999823570251},{"id":"https://openalex.org/keywords/zuma-7","display_name":"ZUMA-7","score":0.6349999904632568},{"id":"https://openalex.org/keywords/product-attributes","display_name":"product attributes","score":0.4950000047683716},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.367000013589859},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7574853897094727},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5655150413513184},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5233342051506042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5192087292671204},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.48578953742980957},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.47876444458961487},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47037404775619507},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4363553524017334},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4161801338195801},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33850452303886414},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27299487590789795},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2666212320327759},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09686684608459473},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-ct004","doi":"https://doi.org/10.1158/1538-7445.am2022-ct004","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct004","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388819539","https://openalex.org/W3177633803","https://openalex.org/W2900884053","https://openalex.org/W2740662496","https://openalex.org/W3094864391","https://openalex.org/W3045009269","https://openalex.org/W4310163529","https://openalex.org/W2891496270","https://openalex.org/W4379981735","https://openalex.org/W3217322350"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Axi-cel":[2],"is":[3],"an":[4],"autologous":[5],"anti-CD19":[6],"chimeric":[7],"antigen":[8],"receptor":[9],"(CAR)":[10],"T-cell":[11,109,146,180,390],"therapy":[12,44],"approved":[13],"for":[14,117,486],"the":[15,154,157,368,417,483],"treatment":[16,162],"of":[17,27,39,161,205,281,293,306,332,335,352,412,463,482],"relapsed":[18],"or":[19],"refractory":[20],"large":[21,476],"B-cell":[22,477],"lymphoma":[23,478],"after":[24],"\u22652":[25],"lines":[26],"systemic":[28],"therapy.":[29],"ZUMA-7,":[30],"a":[31,330,388],"global":[32],"Phase":[33],"3":[34,371],"randomized":[35,369],"study,":[36],"showed":[37],"superiority":[38],"axi-cel":[40,82,101,108,316,347,361,395],"over":[41],"standard":[42],"second-line":[43,475],"(N=359;":[45],"event-free":[46],"survival":[47],"[EFS]":[48],"HR":[49],"0.398,":[50],"P<.0001;":[51],"median":[52,140],"EFS":[53,60],"8.3":[54],"vs":[55,62,69,325],"2":[56],"months;":[57],"estimated":[58],"2-year":[59],"41%":[61],"16%;":[63],"objective":[64],"response":[65,206,265],"rate":[66],"[ORR]":[67],"83%":[68],"50%,":[70],"Locke":[71,132],"et":[72,128,133],"al.":[73,129,134],"N":[74],"Engl":[75],"J":[76],"Med.":[77],"2021).":[78],"Here":[79],"we":[80],"report":[81],"pharmacokinetics":[83],"(PK),":[84],"pharmacodynamics":[85],"(PD),":[86],"and":[87,107,121,151,173,182,189,192,223,231,239,256,263,277,291,296,339,363,378,381,423,472],"product":[88,385],"attributes":[89,462],"associated":[90,233,258,285,375],"with":[91,119,185,203,234,259,278,286,356,376,470],"ZUMA-7":[92,372],"clinical":[93],"outcomes.":[94,421],"Methods:":[95],"Samples":[96],"from":[97],"patients":[98,313,344],"who":[99,314,345],"received":[100,315,346],"(n=170)":[102],"were":[103,115,164,232,310,341,374],"analyzed.":[104],"PK,":[105],"PD,":[106],"composition":[110,386],"(naive,":[111],"CCR7+CD45RA+;":[112],"differentiated,":[113],"CCR7-)":[114],"assessed":[116],"associations":[118],"safety":[120,377],"efficacy":[122,379,471],"using":[123],"previously":[124],"described":[125],"methodologies":[126],"(Neelapu":[127],"NEJM.":[130],"2017;":[131],"Blood":[135],"Adv.":[136],"2020).":[137],"Results:":[138],"The":[139],"(Q1,":[141],"Q3;":[142],"n=162)":[143],"peak":[144,181,228,289],"CAR":[145,179],"level,":[147],"time":[148],"to":[149,405],"peak,":[150],"area":[152],"under":[153],"curve":[155],"within":[156],"first":[158],"28":[159],"days":[160,170],"(AUC0-28)":[163],"25.8":[165],"cells/\u03bcL":[166],"(8.2,":[167],"57.9),":[168],"8":[169],"(8,":[171],"9),":[172],"236.2":[174],"cells/\u03bcL*days":[175],"(76.4,":[176],"758.0),":[177],"respectively.":[178],"AUC0-28":[183,292],"correlated":[184],"higher":[186,287,333,350],"ORR":[187],"(P=.0224":[188],".0054,":[190],"respectively)":[191],"increased":[193,235,260],"Grade":[194],"(Gr)":[195],"\u22653":[196,237,241,308,337],"neurologic":[197],"events":[198],"(NEs;":[199],"P=.0006)":[200],"but":[201],"not":[202],"durability":[204],"(P=.4894).":[207],"Rapid":[208],"transient":[209],"increases":[210],"in":[211,250,272,312,318,343,354,367,402,416,474],"serum":[212,298],"analytes,":[213],"including":[214,410],"granzyme":[215],"B,":[216],"ferritin,":[217,302],"IL-6,":[218],"IL-10,":[219],"CXCL-10,":[220],"IL-15,":[221,301],"ICAM-1,":[222],"GM-CSF,":[224],"occurred":[225],"early":[226],"(median":[227],"\u22647":[229],"days)":[230],"Gr":[236,240,307,336],"NEs":[238,309,338],"cytokine":[242],"release":[243],"syndrome":[244],"(CRS;":[245],"P<.05).":[246],"Infusion":[247],"products":[248,270],"richer":[249,271,317],"naive-like":[251],"T":[252,274,283,320,414],"cells":[253,275,284,321,415],"expressing":[254],"CD27":[255],"CD28":[257],"EFS,":[261],"ORR,":[262],"complete":[264],"(P<.05).":[266],"In":[267],"contrast,":[268],"infusion":[269],"differentiated":[273],"(CCR7-)":[276],"lower":[279],"%":[280],"CCR7+CD45RA+":[282],"postinfusion":[288,364],"levels":[290,351],"several":[294],"proinflammatory":[295],"immunomodulatory":[297],"analytes":[299],"(eg,":[300],"IFN-\u03b3).":[303],"Increased":[304],"rates":[305,334],"found":[311],"CCR7-":[319],"(above":[322],"median:":[323,327],"30%":[324],"below":[326],"10%).":[328],"Similarly,":[329],"trend":[331],"CRS":[340],"observed":[342],"that":[348,383,467],"secreted":[349],"IFN-\u03b3":[353],"co-culture":[355],"CD19-expressing":[357],"targets.":[358],"Conclusions:":[359],"Preinfusion":[360],"features":[362],"PK/PD":[365],"profiles":[366],"phase":[370],"trial":[373],"outcomes":[380],"supported":[382],"optimizing":[384],"towards":[387],"juvenile":[389],"phenotype":[391],"(CCR7+CD45RA+)":[392],"may":[393],"improve":[394,420],"therapeutic":[396],"index.":[397],"These":[398],"findings":[399],"could":[400,419],"result":[401],"future":[403],"trials":[404],"evaluate":[406],"if":[407],"preemptive":[408],"interventions,":[409],"enrichment":[411],"naive":[413],"product,":[418],"[SF":[422],"SV":[424],"contributed":[425],"equally]":[426],"Citation":[427],"Format:":[428],"Simone":[429],"Filosto,":[430],"Saran":[431],"Vardhanabhuti,":[432],"Miguel":[433],"Canales,":[434],"Xavier":[435],"Poir\u00e9,":[436],"Lazaros":[437],"J.":[438],"Lekakis,":[439],"Sven":[440],"de":[441],"Vos,":[442],"Craig":[443],"A.":[444],"Portell,":[445],"Zixing":[446],"Wang,":[447],"Christina":[448],"To,":[449],"Paul":[450],"Cheng,":[451],"Justin":[452],"Chou,":[453],"Adrian":[454],"Bot,":[455],"Rhine":[456],"Shen,":[457],"Jason":[458],"R.":[459],"Westin.":[460],"Product":[461],"axicabtagene":[464],"ciloleucel":[465],"(axi-cel)":[466],"associate":[468],"differentially":[469],"toxicity":[473],"[abstract].":[479],"In:":[480],"Proceedings":[481],"American":[484],"Association":[485],"Cancer":[487,498],"Research":[488],"Annual":[489],"Meeting":[490],"2022;":[491],"2022":[492],"Apr":[493],"8-13.":[494],"Philadelphia":[495],"(PA):":[496],"AACR;":[497],"Res":[499],"2022;82(12_Suppl):Abstract":[500],"nr":[501],"CT004.":[502]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-06-17T00:00:00"}